Cargando…
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies
BACKGROUND: At the beginning of the SARS-CoV-2 pandemic, there was a lack of information about the infection’s impact on pregnancy and capability to induce de novo autoantibodies. It soon became clear that thrombosis was a manifestation of COVID-19, therefore the possible contribution of de novo ant...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520906/ https://www.ncbi.nlm.nih.gov/pubmed/36189273 http://dx.doi.org/10.3389/fimmu.2022.953043 |
_version_ | 1784799728842571776 |
---|---|
author | Gozzoli, Giorgia Ingrid Piovani, Elda Negri, Beatrice Mascherpa, Margaret Orabona, Rossana Zanardini, Cristina Zatti, Sonia Piantoni, Silvia Lazzaroni, Maria Grazia Tomasi, Cesare Prefumo, Federico Sartori, Enrico Franceschini, Franco Tincani, Angela Andreoli, Laura |
author_facet | Gozzoli, Giorgia Ingrid Piovani, Elda Negri, Beatrice Mascherpa, Margaret Orabona, Rossana Zanardini, Cristina Zatti, Sonia Piantoni, Silvia Lazzaroni, Maria Grazia Tomasi, Cesare Prefumo, Federico Sartori, Enrico Franceschini, Franco Tincani, Angela Andreoli, Laura |
author_sort | Gozzoli, Giorgia Ingrid |
collection | PubMed |
description | BACKGROUND: At the beginning of the SARS-CoV-2 pandemic, there was a lack of information about the infection’s impact on pregnancy and capability to induce de novo autoantibodies. It soon became clear that thrombosis was a manifestation of COVID-19, therefore the possible contribution of de novo antiphospholipid antibodies (aPL) raised research interest. We aimed at screening SARS-CoV-2 positive pregnant patients for aPL. METHODS: The study included consecutive pregnant women who were hospitalized in our Obstetric Department between March 2020 and July 2021 for either a symptomatic SARS-CoV-2 infection or for other reasons (obstetric complications, labour, delivery) and found positive at the admission nasopharyngeal swab. All these women underwent the search for aPL by means of Lupus Anticoagulant (LA), IgG/IgM anti-cardiolipin (aCL), IgG/IgM anti-beta2glycoprotein I (aB2GPI). Data about comorbidities, obstetric and neonatal complications were collected. RESULTS: 151 women were included. Sixteen (11%) were positive for aPL, mostly at low titre. Pneumonia was diagnosed in 20 women (5 with positive aPL) and 5 required ICU admission (2 with positive aPL). Obstetric complications occurred in 10/16 (63%) aPL positive and in 36/135 (27%) negative patients. The occurrence of HELLP syndrome and preeclampsia was significantly associated with positive aPL (p=0,004). One case of maternal thrombosis occurred in an aPL negative woman. aPL positivity was checked after at least 12 weeks in 7/16 women (44%): 3 had become negative; 2 were still positive (1 IgG aB2GPI + IgG aCL; 1 IgM aB2GPI); 1 remained positive for IgG aCL but became negative for aB2GPI; 1 became negative for LA but displayed a new positivity for IgG aCL at high titre. CONCLUSIONS: The frequency of positive aPL in pregnant women with SARS-CoV-2 infection was low in our cohort and similar to the one described in the general obstetric population. aPL mostly presented as single positive, low titre, transient antibodies. The rate of obstetric complications was higher in aPL positive women as compared to negative ones, particularly hypertensive disorders. Causality cannot be excluded; however, other risk factors, including a full-blown picture of COVID-19, may have elicited the pathogenic potential of aPL and contributed themselves to the development of complications. |
format | Online Article Text |
id | pubmed-9520906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95209062022-09-30 Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies Gozzoli, Giorgia Ingrid Piovani, Elda Negri, Beatrice Mascherpa, Margaret Orabona, Rossana Zanardini, Cristina Zatti, Sonia Piantoni, Silvia Lazzaroni, Maria Grazia Tomasi, Cesare Prefumo, Federico Sartori, Enrico Franceschini, Franco Tincani, Angela Andreoli, Laura Front Immunol Immunology BACKGROUND: At the beginning of the SARS-CoV-2 pandemic, there was a lack of information about the infection’s impact on pregnancy and capability to induce de novo autoantibodies. It soon became clear that thrombosis was a manifestation of COVID-19, therefore the possible contribution of de novo antiphospholipid antibodies (aPL) raised research interest. We aimed at screening SARS-CoV-2 positive pregnant patients for aPL. METHODS: The study included consecutive pregnant women who were hospitalized in our Obstetric Department between March 2020 and July 2021 for either a symptomatic SARS-CoV-2 infection or for other reasons (obstetric complications, labour, delivery) and found positive at the admission nasopharyngeal swab. All these women underwent the search for aPL by means of Lupus Anticoagulant (LA), IgG/IgM anti-cardiolipin (aCL), IgG/IgM anti-beta2glycoprotein I (aB2GPI). Data about comorbidities, obstetric and neonatal complications were collected. RESULTS: 151 women were included. Sixteen (11%) were positive for aPL, mostly at low titre. Pneumonia was diagnosed in 20 women (5 with positive aPL) and 5 required ICU admission (2 with positive aPL). Obstetric complications occurred in 10/16 (63%) aPL positive and in 36/135 (27%) negative patients. The occurrence of HELLP syndrome and preeclampsia was significantly associated with positive aPL (p=0,004). One case of maternal thrombosis occurred in an aPL negative woman. aPL positivity was checked after at least 12 weeks in 7/16 women (44%): 3 had become negative; 2 were still positive (1 IgG aB2GPI + IgG aCL; 1 IgM aB2GPI); 1 remained positive for IgG aCL but became negative for aB2GPI; 1 became negative for LA but displayed a new positivity for IgG aCL at high titre. CONCLUSIONS: The frequency of positive aPL in pregnant women with SARS-CoV-2 infection was low in our cohort and similar to the one described in the general obstetric population. aPL mostly presented as single positive, low titre, transient antibodies. The rate of obstetric complications was higher in aPL positive women as compared to negative ones, particularly hypertensive disorders. Causality cannot be excluded; however, other risk factors, including a full-blown picture of COVID-19, may have elicited the pathogenic potential of aPL and contributed themselves to the development of complications. Frontiers Media S.A. 2022-09-15 /pmc/articles/PMC9520906/ /pubmed/36189273 http://dx.doi.org/10.3389/fimmu.2022.953043 Text en Copyright © 2022 Gozzoli, Piovani, Negri, Mascherpa, Orabona, Zanardini, Zatti, Piantoni, Lazzaroni, Tomasi, Prefumo, Sartori, Franceschini, Tincani and Andreoli https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Gozzoli, Giorgia Ingrid Piovani, Elda Negri, Beatrice Mascherpa, Margaret Orabona, Rossana Zanardini, Cristina Zatti, Sonia Piantoni, Silvia Lazzaroni, Maria Grazia Tomasi, Cesare Prefumo, Federico Sartori, Enrico Franceschini, Franco Tincani, Angela Andreoli, Laura Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies |
title | Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies |
title_full | Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies |
title_fullStr | Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies |
title_full_unstemmed | Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies |
title_short | Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies |
title_sort | frequency of positive antiphospholipid antibodies in pregnant women with sars-cov-2 infection and impact on pregnancy outcome: a single-center prospective study on 151 pregnancies |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520906/ https://www.ncbi.nlm.nih.gov/pubmed/36189273 http://dx.doi.org/10.3389/fimmu.2022.953043 |
work_keys_str_mv | AT gozzoligiorgiaingrid frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT piovanielda frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT negribeatrice frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT mascherpamargaret frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT orabonarossana frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT zanardinicristina frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT zattisonia frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT piantonisilvia frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT lazzaronimariagrazia frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT tomasicesare frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT prefumofederico frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT sartorienrico frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT franceschinifranco frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT tincaniangela frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies AT andreolilaura frequencyofpositiveantiphospholipidantibodiesinpregnantwomenwithsarscov2infectionandimpactonpregnancyoutcomeasinglecenterprospectivestudyon151pregnancies |